MedTrace Logo

Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas

NCT00646308 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2011-04-26

No results posted yet for this study

Summary

The purpose of this study is to determine if patients with a history of nonsecreting pituitary adenomas with untreated GH deficient patients have profiles consistent with increased cardiovascular risk compared to patients without GH deficiency who have undergone similar surgery.

Conditions

  • Growth Hormone Deficiency
  • Pituitary Tumor

Sponsors & Collaborators

Principal Investigators

  • Pamela U Freda, MD · Columbia University College of P & S

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2010-01-31
Completion
2010-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00646308 on ClinicalTrials.gov